Skip to Content
MilliporeSigma
  • Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates.

Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates.

PloS one (2015-02-20)
Guilian Li, Jingrui Zhang, Qian Guo, Yi Jiang, Jianhao Wei, Li-li Zhao, Xiuqin Zhao, Jianxin Lu, Kanglin Wan
ABSTRACT

Isoniazid (INH) and rifampicin (RIF) are the two most effective drugs in tuberculosis therapy. Understanding the molecular mechanisms of resistance to these two drugs is essential to quickly diagnose multidrug-resistant (MDR) tuberculosis and extensive drug-resistant tuberculosis. Nine clinical Mycobacterium tuberculosis isolates resistant to only INH and RIF and 10 clinical pan-sensitive isolates were included to evaluate the expression of 20 putative drug efflux pump genes and sequence mutations in rpoB (RIF), katG (INH), the inhA promoter (INH), and oxyR-ahpC (INH). Nine and three MDR isolates were induced to overexpress efflux pump genes by INH and RIF, respectively. Eight and two efflux pump genes were induced to overexpress by INH and RIF in MDR isolates, respectively. drrA, drrB, efpA, jefA (Rv2459), mmr, Rv0849, Rv1634, and Rv1250 were overexpressed under INH or RIF stress. Most efflux pump genes were overexpressed under INH stress in a MDR isolates that carried the wild-type katG, inhA, and oxyR-ahpC associated with INH resistance than in those that carried mutations. The expression levels of 11 genes (efpA, Rv0849, Rv1250, P55 (Rv1410c), Rv1634, Rv2994, stp, Rv2459, pstB, drrA, and drrB) without drug inducement were significantly higher (P < 0.05) in nine MDR isolates than in 10 pan-sensitive isolates. In conclusion, efflux pumps may play an important role in INH acquired resistance in MDR M. tuberculosis, especially in those strains having no mutations in genes associated with INH resistance; basal expression levels of some efflux pump genes are higher in MDR isolates than in pan-sensitive isolates and the basal expressional differences may be helpful to diagnose and treat resistant tuberculosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
7-Diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin, suitable for fluorescence, BioReagent, ≥90% (HPCE)
Sigma-Aldrich
7-Diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin, ≥95% (HPLC), solid
Supelco
Reserpine Standard for LC-MS, analytical standard, for LC-MS
Supelco
Ofloxacin, VETRANAL®, analytical standard
Supelco
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Reserpine, crystallized, ≥99.0% (HPLC)
Sigma-Aldrich
Carbonyl cyanide 3-chlorophenylhydrazone, ≥97% (TLC), powder
Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Reserpine
Reserpine, European Pharmacopoeia (EP) Reference Standard
Isoniazid, European Pharmacopoeia (EP) Reference Standard
USP
Amikacin, United States Pharmacopeia (USP) Reference Standard